Personalized Alternatives: When PlexusDx Compounded Therapy May Be Right for You Not everyone needs dual commercial medications to achieve weight loss and metabolic health
As increased usage of Glucagon-like peptide medications, or GLP-1s, sweeps the country and reshapes consumer behavior, a noticeable shift toward healthier choices continues to permeate the market, presenting both challenges and opportunities for Consumer Goods Manufacturers and Retailers
Microneedling offers a valuable solution for anyone dealing with acne scars
Meanwhile, Aon found, GLP-1 use reduces cancer risk for women: Female GLP-1 users experienced a 47% reduction in hospitalizations for major cardiovascular events, approximately 50% lower incidence of ovarian cancer, and a 14% lower incidence of breast cancer, compared to female non-users, according to the analysis